| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/20/1995 | WO1995010632A1 Anti-paramyxovirus screening method and vaccine |
| 04/20/1995 | WO1995010630A1 Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins |
| 04/20/1995 | WO1995010628A2 Signal transduction via cd28 |
| 04/20/1995 | WO1995010625A1 Dna encoding 1,3-beta-d glucan synthase subunits |
| 04/20/1995 | WO1995010620A1 A plasmid vector useful for the expression of a foreign dna sequence |
| 04/20/1995 | WO1995010616A2 USE OF α-1,4-GLUCAN LYASE FOR PREPARATION OF 1,5-D-ANHYDROFRUCTOSE |
| 04/20/1995 | WO1995010614A1 Recombinant staphylococcal nucleases and their use in limiting the survival of genetically engineered microorganisms |
| 04/20/1995 | WO1995010612A1 FIMBRILLIN PROTEIN OF $i(PORPHYROMONAS GINGIVALIS) |
| 04/20/1995 | WO1995010611A1 Method of inducing and maintaining neuronal cells |
| 04/20/1995 | WO1995010610A1 BETAGLYCAN POLYPEPTIDES HAVING TGF-β BINDING ACTIVITY |
| 04/20/1995 | WO1995010606A1 Deoxyribonucleic acids containing inactivated hormone responsive elements |
| 04/20/1995 | WO1995010539A1 Growth differentiation factor-10 |
| 04/20/1995 | WO1995010538A1 Dna encoding the human p2u receptor and null cells expressing p2u receptors |
| 04/20/1995 | WO1995010536A1 Membrane protein polypeptide having function of supporting pre-b cell growth and gene therefor |
| 04/20/1995 | WO1995010534A1 Polypeptide and anti-hiv agent prepared therefrom |
| 04/20/1995 | WO1995010533A1 Peptides for tumour therapy |
| 04/20/1995 | WO1995010531A1 Oligopeptides derived from c-reactive protein fragments |
| 04/20/1995 | WO1995010530A1 An aglucone isoflavone enriched vegetable protein extract and isolate and process for producing |
| 04/20/1995 | WO1995010529A1 An aglucone isoflavone enriched vegetable protein concentrate and process for producing |
| 04/20/1995 | WO1995010526A1 Plasmodium falciparum ribonucleotide reductase, encoding dna, and inhibitors |
| 04/20/1995 | WO1995010512A1 An aglucone isoflavone enriched vegetable protein whey, whey protein, and process for producing |
| 04/20/1995 | WO1995010302A1 Cellular and serum protein anchors and conjugates |
| 04/20/1995 | WO1995010300A1 Vibrio cholerae 01 (cvd111) and non-01 (cvd112 and cvd112rm) serogroup vaccine strains and methods of making same |
| 04/20/1995 | WO1995010299A1 COMPOSITION FOR TREATMENT BY IMMUNOTHERAPY OF A CANCER SECRETING hCG OR hCG FRAGMENTS |
| 04/20/1995 | WO1995010298A1 Method of contraception |
| 04/20/1995 | WO1995010297A1 Method of treating depressed reticuloendothelial system function |
| 04/20/1995 | WO1995010288A1 Hepatitis b virus interacts with cellular dna repair processes |
| 04/20/1995 | WO1995010273A1 Use of protein kinase c activators for the manufacture of a medicament for killing hypoxic tumor cells |
| 04/20/1995 | WO1995010217A2 Functionalized aza-cryptand ligands for imaging applications |
| 04/20/1995 | WO1995010185A1 Superoxide dismutase and mimetics thereof |
| 04/20/1995 | CA2174136A1 Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins |
| 04/20/1995 | CA2174120A1 An aglucone isoflavone enriched vegetable protein concentrate and process for producing |
| 04/20/1995 | CA2174089A1 Plasmodium falciparum ribonucleotide reductase, encoding dna, and inhibitors |
| 04/20/1995 | CA2173751A1 Recombinant staphylococcal nucleases and their use in limiting the survival of genetically engineered microorganisms |
| 04/20/1995 | CA2173743A1 An aglucone isoflavone enriched vegetable protein extract and isolate and process for producing |
| 04/20/1995 | CA2173606A1 Vibrio cholerae 01 (cvd111) and non-01 (cvd112 and cvd112rm) serogroup vaccine strains, methods of making same and products thereof |
| 04/20/1995 | CA2172271A1 Deoxyribonucleic acids containing inactivated hormone responsive elements |
| 04/20/1995 | CA2171546A1 Growth differentiation factor-10 |
| 04/20/1995 | CA2151283A1 Polypeptide and anti-hiv agent prepared therefrom |
| 04/20/1995 | CA2118454A1 Composition for inhibiting ige production |
| 04/19/1995 | EP0648842A2 Truncated human cholesterol 7alpha-hydroxylase, method of production and use thereof |
| 04/19/1995 | EP0648841A2 Genomic DNA of human Cholesterol 7alpha-hydroxylase and methods for using it |
| 04/19/1995 | EP0648840A2 Cholesterol 7alpha-hydroxylase gene regulatory elements and transcription factors |
| 04/19/1995 | EP0648839A1 Bibenzylsynthase gene |
| 04/19/1995 | EP0648838A1 Tissue inhibitor of metalloproteinase type three (TIMP-3) |
| 04/19/1995 | EP0648837A1 Porcine vasoactive intestinal peptide receptor |
| 04/19/1995 | EP0648836A1 MHC class II transactivator (CIITA) and uses thereof |
| 04/19/1995 | EP0648783A1 TNF inhibitors |
| 04/19/1995 | EP0648782A1 Composition containing hematopoiesis inhibitor |
| 04/19/1995 | EP0648780A1 Heterocyclic thrombin inhibitors |
| 04/19/1995 | EP0648501A1 Compositions comprising G-CSF for treating or preventing infections in canine and feline animals |
| 04/19/1995 | EP0648499A1 Composition for inhibiting IgE production |
| 04/19/1995 | EP0648493A1 A method to reverse the phenotype of transformed cells by the transcription factor IRF-1 |
| 04/19/1995 | EP0648279A1 Acceptor for fucosyltransferase |
| 04/19/1995 | EP0648276A1 Monoclonal antibodies to glycoprotein p |
| 04/19/1995 | EP0648275A1 Method for the epigenetic regulation of protein biosynthesis by scale resonance |
| 04/19/1995 | EP0648271A1 Adenovirus mediated transfer of genes to the gastrointestinal tract |
| 04/19/1995 | EP0648270A1 Cloning of gene encoding the gp28.5 protein of toxoplasma gondii; peptide fragments of said protein and their applications |
| 04/19/1995 | EP0648269A1 Novel polypeptides having nmda receptor activity, nucleic acids encoding said polypeptides and applications |
| 04/19/1995 | EP0648268A1 Therapeutic fragments of von willebrand factor |
| 04/19/1995 | EP0648266A1 Elicitor of the hypersensitive response in plants |
| 04/19/1995 | EP0648265A1 Methods for producing transgenic non-human animals harboring a yeast artificial chromosome |
| 04/19/1995 | EP0648264A1 Bandage for continuous application of biologicals |
| 04/19/1995 | EP0648260A1 Fusobacterium necrophorum leukotoxoid vaccine |
| 04/19/1995 | EP0648239A1 Biocompatible polymer conjugates |
| 04/19/1995 | EP0648228A1 Bnp antibody and immunoassay using it |
| 04/19/1995 | EP0648227A1 Improvements in or relating to neuroregeneration |
| 04/19/1995 | EP0648225A1 Compositions for the inhibition of protein hormone formation and uses thereof |
| 04/19/1995 | EP0648224A1 Conformationally restrained peptide analogs as antiplatelet agents |
| 04/19/1995 | EP0648222A1 Methods of single nucleotide primer extension to detect specific alleles and kits therefor |
| 04/19/1995 | EP0648127A1 Type i and type ii surface antigens associated with staphylococcus epidermidis |
| 04/19/1995 | EP0648078A1 Purification of zein from corn gluten meal |
| 04/19/1995 | EP0579726A4 Chimeric plant genes based on upstream regulatory elements of helianthinin. |
| 04/19/1995 | EP0570375B1 Novel peptides with anticoagulatory effect |
| 04/19/1995 | EP0550683B1 Vaccine suitable for combatting bordetella pertussis |
| 04/19/1995 | EP0541822B1 Novel calcitonin, and production and use thereof |
| 04/19/1995 | EP0531404B1 Ubiquitin-specific protease |
| 04/19/1995 | EP0497915B1 hPTH (1-37) FRAGMENT, ITS PRODUCTION, DRUG CONTAINING IT AND ITS USE |
| 04/19/1995 | EP0407392B1 UNIQUE ANTIGENIC EPITOPES ON IgE-BEARING B LYMPHOCYTES |
| 04/19/1995 | CN1101572A Tumor metastasis-suppressing agent and veterinary tumor metastasis-suppressing agent |
| 04/19/1995 | CN1028237C Composition for stimulating chondrocytes and osteoblasts, method for its production |
| 04/19/1995 | CN1028206C Purification of pertussis antigens |
| 04/19/1995 | CA2117843A1 Agent for suppressing the motor activity of gastrointestinal tracts |
| 04/18/1995 | US5408041 Multiple elutions with Sepharose, Sephacryl, HPLC; for bone disorders, osteoporosis, Paget*s disease |
| 04/18/1995 | US5408040 Connective tissue growth factor(CTGF) |
| 04/18/1995 | US5408039 Repeated ion exchanging of plasma cryoprecipitate, then affinity chromatography of effluent |
| 04/18/1995 | US5408038 Nonnatural apolipoprotein B-100 peptides and apolipoprotein B-100-apolipoprotein A-I fusion peptides |
| 04/18/1995 | US5408037 Methods for detecting glucagon antagonists |
| 04/18/1995 | US5407915 Human Bikunin variants as proteinase inhibitors, and medicaments containing these |
| 04/18/1995 | US5407914 Pulmonary surfactant protein and related polypeptides |
| 04/18/1995 | US5407912 Method of treating bladder cancer with a keyhole limpet hemocyanin composition with enhanced anti-tumor activity |
| 04/18/1995 | US5407835 Reagents and methods for the quantification of amitriptyline or nortriptyline in biological fluids |
| 04/18/1995 | US5407834 Phencyclidine and phencyclidine metabolites assay, tracers, immunogens, antibodies and reagent kit |
| 04/18/1995 | US5407833 For forming detectable complexes with autoimmune antibodies, kits |
| 04/18/1995 | US5407825 Bacillus thuringiensis isolates active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins |
| 04/18/1995 | US5407823 Polypeptides having a dopaminergic receptor activity, nucleic acids coding for these polypeptides and use of these polypeptides for the screening of substances active on these polypeptides |
| 04/18/1995 | US5407822 Artificial promoter for the expression of proteins in yeast |
| 04/18/1995 | US5407820 Calcium channel α-2 subunit DNAs and cells expressing them |
| 04/18/1995 | US5407810 Using chaotropic agent to extract exogenous peptide in non-native conformation in phase of polymer and salt |
| 04/18/1995 | US5407796 Cystic fibrosis mutation cluster |